La bourse est fermée
  • CAC 40

    4 594,24
    +24,57 (+0,54 %)
     
  • Euro Stoxx 50

    2 958,21
    -1,82 (-0,06 %)
     
  • Dow Jones

    26 280,51
    -378,60 (-1,42 %)
     
  • EUR/USD

    1,1654
    -0,0024 (-0,21 %)
     
  • Gold future

    1 878,90
    +10,90 (+0,58 %)
     
  • BTC-EUR

    11 600,91
    +213,04 (+1,87 %)
     
  • CMC Crypto 200

    264,11
    +0,48 (+0,18 %)
     
  • Pétrole WTI

    35,45
    -0,72 (-1,99 %)
     
  • DAX

    11 556,48
    -41,59 (-0,36 %)
     
  • FTSE 100

    5 577,27
    -4,48 (-0,08 %)
     
  • Nasdaq

    10 872,19
    -313,40 (-2,80 %)
     
  • S&P 500

    3 248,62
    -61,49 (-1,86 %)
     
  • Nikkei 225

    22 977,13
    -354,81 (-1,52 %)
     
  • HANG SENG

    24 107,42
    -479,18 (-1,95 %)
     
  • GBP/USD

    1,2954
    +0,0030 (+0,23 %)
     

The Global Xerostomia Therapeutics Market is expected to grow by $ 133.27 mn during 2020-2024 progressing at a CAGR of 4% during the forecast period

ReportLinker
·2 min de lecture

Global Xerostomia Therapeutics Market 2020-2024 The analyst has been monitoring the xerostomia therapeutics market and it is poised to grow by $ 133. 27 mn during 2020-2024 progressing at a CAGR of 4% during the forecast period.

New York, Oct. 12, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Xerostomia Therapeutics Market 2020-2024" - https://www.reportlinker.com/p05678715/?utm_source=GNW
Our reports on xerostomia therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing awareness of xerostomia and growing geriatric population. In addition, increasing awareness of xerostomia is anticipated to boost the growth of the market as well.
The xerostomia therapeutics market analysis includes product segment and geographical landscapes

The xerostomia therapeutics market is segmented as below:
By Product
• OTC
• Prescription

By Geographical Landscapes
• North America
• Europe
• Asia
• ROW

This study identifies the high risk factors for xerostomia as one of the prime reasons driving the xerostomia therapeutics market growth during the next few years.

The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our xerostomia therapeutics market covers the following areas:
• Xerostomia therapeutics market sizing
• Xerostomia therapeutics market forecast
• Xerostomia therapeutics market industry analysis


Read the full report: https://www.reportlinker.com/p05678715/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001